FDA approves Purdue's painkiller that can reduce abuse

November 20, 2014 7:05 PM

12 0

(Reuters) - The U.S. Food and Drug Administration has approved a long-acting narcotic painkiller with abuse-resistant properties made by Purdue Pharma L.P., the agency said on Thursday.

The FDA approved the once-daily drug, Hysingla ER, with the expectation that it will reduce, though not necessarily prevent, abuse through snorting or injecting.

Read more

To category page